home / stock / achv / achv news

ACHV News and Press, Achieve Life Sciences Inc. From 12/19/19

Stock Information
Company Name: Achieve Life Sciences Inc.
Stock Symbol: ACHV
Market: NASDAQ
Website: achievelifesciences.com
Menu
ACHV ACHV Quote ACHV Short ACHV News ACHV Articles ACHV Message Board
Get ACHV Alerts

News, Short Squeeze, Breakout and More Instantly...
ACHV - Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option

Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Dec. 19, 2019 SEATTLE and VANCOUVER, British Columbia , Dec. 19, 2019 ...
ACHV - Achieve Life Sciences down 34% after pricing equity offering

Achieve Life Sciences ( ACHV -34.1% ) is down on a robust 90x surge in volume in response to its $12M public offering of Class A & B units. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

ACHV - AUPH, DBI, FRAN and NLTX among midday movers

Gainers:  Technical Communications (NASDAQ: TCCO ) +323% . More news on: Technical Communications Corporation, Venus Concept Inc., Iterum Therapeutics plc, Stocks on the move, Read more ...

ACHV - Achieve +22% premarket after FDA meeting on cytisinicline development program

Achieve Life Sciences (NASDAQ: ACHV ) announces an update on the cytisinicline clinical development program. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...

ACHV - Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program

SEATTLE and VANCOUVER, British Columbia , Dec. 9, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...

ACHV - Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q3 2019 Results - Earnings Call Transcript

Achieve Life Sciences, Inc. (ACHV) Q3 2019 Earnings Conference Call November 6, 2019 8:00 AM ET Company Participants Jaime Xinos - Executive Vice President of Commercial Rick Stewart - Chief Executive Officer John Bencich - Chief Financial and Operating Officer Cindy Jacobs - C...

ACHV - Earnings dominate premarket losers

Fluidigm (NASDAQ: FLDM ) -31%  on Q3 results . More news on: Fluidigm Corporation, Plantronics, Inc., Amneal Pharmaceuticals, Inc., Stocks on the move, Read more ...

ACHV - Achieve Life Sciences EPS misses by $0.15

Achieve Life Sciences (NASDAQ: ACHV ): Q3 GAAP EPS of -$0.45 misses by $0.15 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

ACHV - Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program

SEATTLE and VANCOUVER, British Columbia , Nov. 6, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...

ACHV - Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019

SEATTLE and VANCOUVER, British Columbia , Oct. 31, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotin...
Previous 10 Next 10